German China

USA: Long-Term Collaboration Moderna Partners with Thermo Fisher Scientific to Produce Covid-19 Vaccines, Other Medicines

Source: Press release

Under a 15-year strategic collaboration agreement signed between Moderna and Thermo Fisher Scientific, both the firms will work together to ensure large-scale manufacturing of Moderna’s Covid-19 vaccine, and other investigational mRNA drugs in the USA.

Related Vendors

Over the past several years, Thermo Fisher has been partnering with Moderna to support its development pipeline with both clinical research and contract manufacturing services.
Over the past several years, Thermo Fisher has been partnering with Moderna to support its development pipeline with both clinical research and contract manufacturing services.
(Source: Pixabay)

Cambridge/UK – Moderna and Thermo Fisher Scientific have announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax, Moderna’s Covid-19 vaccine, and other investigational mRNA medicines in its pipeline.

Over the past several years, Thermo Fisher has been partnering with Moderna to support its development pipeline with both clinical research and contract manufacturing services. This included the quick scale-up of aseptic fill-finish services and packaging of its COVID-19 vaccine. As part of this expanded agreement, Thermo Fisher will now provide dedicated capacity for a range of aseptic fill-finish services including lyophilized and liquid filling. In addition, the company will provide inspection, labeling and final packaging services.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:48033317)